What is the best PRN (pro re nata) dose of Ativan (lorazepam) for IM administration in a patient with impaired renal function and a history of seizures, weighing 170 pounds?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IM Lorazepam Dosing for 170 lb Patient

For a 170 lb (77 kg) patient requiring PRN IM lorazepam, order 2-4 mg IM every 10-15 minutes as needed, with careful attention to renal function and respiratory monitoring.

Recommended Dosing Strategy

The standard IM lorazepam dose is 0.05-0.10 mg/kg, which translates to approximately 4 mg for this patient (maximum 4 mg per dose). 1 However, given the context of impaired renal function and seizure history, specific considerations apply:

Weight-Based Calculation

  • Patient weight: 170 lbs = 77 kg
  • Standard dosing range: 0.05-0.10 mg/kg 1
  • Calculated dose: 3.85-7.7 mg
  • Practical order: 2-4 mg IM per dose (maximum 4 mg per single dose) 1

Dosing Interval

  • May repeat every 10-15 minutes if seizures continue 1
  • Monitor closely for respiratory depression between doses 1

Critical Considerations for Renal Impairment

Lorazepam clearance is NOT significantly affected by renal dysfunction, so standard dosing can be used. 2 This is a crucial distinction:

  • Lorazepam is primarily eliminated via hepatic glucuronidation, not renal excretion 2
  • The inactive glucuronide metabolite accumulates in renal failure but is nontoxic 2
  • Drug clearance remains approximately 85 ml/min in renal patients vs 71 ml/min in normal patients (not statistically significant) 2
  • No dosage adjustment is necessary for renal impairment 2

Important Caveat - Propylene Glycol Toxicity

Avoid prolonged or high-dose continuous infusions in renal patients due to propylene glycol vehicle accumulation. 3 The vehicle can cause:

  • Hyperlactatemia 3
  • Elevated osmolar gap 3
  • Impaired renal tubular function 3
  • Blunted renal compensation for respiratory acidosis 3

However, this concern applies primarily to continuous infusions, not intermittent IM dosing 3

Seizure Management Context

For status epilepticus, underdosing lorazepam significantly increases progression to refractory status epilepticus. 4 Key evidence:

  • Patients receiving less than 4 mg had 87% progression to refractory SE vs 62% with 4 mg dosing (p=0.03) 4
  • The recommended IV dose is 0.1 mg/kg up to maximum 4 mg 4
  • Do not underdose - use the full 4 mg when indicated for seizures 4

For IM administration specifically in seizures: 0.2 mg/kg (maximum 6 mg per dose) may be used, repeating every 10-15 minutes 1

Safety Monitoring Requirements

Prepare for respiratory support regardless of administration route: 1

  • Increased apnea risk when combined with other sedatives 1
  • Monitor oxygen saturation continuously 1
  • Have flumazenil available for life-threatening respiratory depression (though it may precipitate seizure recurrence) 1
  • Peak effect occurs 3-5 minutes after IV dosing; IM onset within approximately 5 minutes 1

Practical PRN Order

Recommended order format:

  • Lorazepam 2-4 mg IM PRN for agitation/seizures
  • Maximum single dose: 4 mg
  • May repeat every 10-15 minutes if needed
  • Maximum total dose per episode: Consider consultation if >12 mg required
  • Hold for respiratory rate <10 or oversedation
  • Monitor respiratory status and oxygen saturation

Dose Selection Within Range

  • Start with 2 mg for agitation/anxiety 1
  • Use 4 mg for seizure activity 1, 4
  • Renal impairment does not require dose reduction 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.